Hangzhou Ruidi Biotechnology Ltd.
PrivateLast Round
Series B
Extension
Feb 11, 2025
Total Funding Raised
$48.1M
Company Overview
Hangzhou Ruidi Biotechnology Ltd. operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series B Extension round in February 2025.
Hangzhou Ruidi Biotechnology Ltd. is a medical device company that develops nanosecond pulsed electric field (nsPEF) ablation systems for the treatment of solid tumors and other medical conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou Ruidi Biotechnology Ltd. Comparables
Compare Hangzhou Ruidi Biotechnology Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pulsecare Medical | 85% | |
| Remedicine Co., Ltd. | 83% | |
| Galvanize Therapeutics | 78% |
For institutional investors. Book with your work email.
Hangzhou Ruidi Biotechnology Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 11, 2025 | ||||
| Series B | Oct 17, 2021 | ||||
| Series A Extension | Oct 28, 2020 | ||||
| Series A | Feb 18, 2019 |
For institutional investors. Book with your work email.
Hangzhou Ruidi Biotechnology Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jifeng Ventures | Series B |
| Zhangjiang Shuifeng Innovation Equity Investment Fund | Series B Extension |
| Proxima Ventures Ltd. | Angel, Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 11, 2025
$14M round with Zhangjiang Shuifeng Innovation and He Haichao.
- Feb 18, 2019
$3M round led by Proxima Ventures Ltd.
For institutional investors. Book with your work email.
Hangzhou Ruidi Biotechnology Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hangzhou Ruidi Biotechnology Ltd.'s valuation, stock price, and market status.
Is Hangzhou Ruidi Biotechnology Ltd. a public or private company?
Hangzhou Ruidi Biotechnology Ltd. is a private company.
What is the current stock price of Hangzhou Ruidi Biotechnology Ltd.?
Hangzhou Ruidi Biotechnology Ltd. is a private company, so its shares have no public market price. Caplight tracks Hangzhou Ruidi Biotechnology Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hangzhou Ruidi Biotechnology Ltd. worth (valuation)?
Valuation information for Hangzhou Ruidi Biotechnology Ltd. is not publicly available.
Can I buy Hangzhou Ruidi Biotechnology Ltd. stock?
Hangzhou Ruidi Biotechnology Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hangzhou Ruidi Biotechnology Ltd.'s last funding round?
Hangzhou Ruidi Biotechnology Ltd.'s most recent funding round was Series B Extension on February 11, 2025.
Who are the main investors in Hangzhou Ruidi Biotechnology Ltd.?
Key investors in Hangzhou Ruidi Biotechnology Ltd. include Jifeng Ventures.
Will Hangzhou Ruidi Biotechnology Ltd. IPO soon?
No public IPO plans have been announced for Hangzhou Ruidi Biotechnology Ltd..
How can I track Hangzhou Ruidi Biotechnology Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Hangzhou Ruidi Biotechnology Ltd.'s shares on secondary markets.